Literature DB >> 3760565

IgG subclasses of anti-tetanus toxoid antibodies in adult and newborn normal subjects and in patients with systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity.

R L Rubin, F L Tang, A H Lucas, H L Spiegelberg, E M Tan.   

Abstract

The IgG subclasses of anti-tetanus toxoid (anti-TT) antibodies were quantitated in normal sera and sera from patients with rheumatic disease. Detection relied on a set of four mouse monoclonal antibodies, each of which showed specificity for the respective isotype, independent of gamma-chain allotype or light chain class of the human antibody. Approximately 90% of the total anti-TT activity in normal adults and patients with Sjogren's syndrome was IgG1. In addition, IgG4 antibodies were detected in one-half the samples, but IgG2 and IgG3 antibodies were observed in only two out of 36 sera. However, antibodies elicited in children immunized with TT were exclusively IgG1 and IgG3, with IgG4 antibodies detectable only at birth (presumably due to transplacental passage of antibody) in three of 12 children. In contrast to normal adults, patients with systemic lupus erythematosus (SLE) and drug-induced autoimmunity (DIA) had a more promiscuous isotype profile. IgG2 and/or IgG3 anti-TT antibodies were detected in 13 of 22 SLE patients and IgG3 antibodies in six of 11 patients with DIA. IgG4 anti-TT antibodies were predominant in seven of these 33 patients. These findings suggest that IgG isotypes may depend on the frequency of the stimulus, but global alterations in immunologic status as reflected in systemic autoimmune disease may override the homeostatic mechanisms that control isotype restriction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760565

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals.

Authors:  S Oak; J Radtke; C Törn; M Landin-Olsson; C S Hampe
Journal:  Scand J Immunol       Date:  2011-10       Impact factor: 3.487

2.  Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin.

Authors:  R W Burlingame; R L Rubin
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

3.  Subclass restriction of human enterovirus antibodies.

Authors:  E G Torfason; C B Reimer; H L Keyserling
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 4.  Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  L Turner-Stokes; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

5.  Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.

Authors:  Uwe Schauer; Frank Stemberg; Christian H L Rieger; Wolfgang Büttner; Michael Borte; Simone Schubert; Helga Möllers; Frank Riedel; Udo Herz; Harald Renz; Wilhelm Herzog
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

6.  Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture.

Authors:  P Bird; J E Calvert; H Mitchison; N R Ling; M Bassendine; O F James
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

Review 7.  IgG subclass-restricted immune responses to allergens.

Authors:  A H Lucas
Journal:  Springer Semin Immunopathol       Date:  1990

8.  Immune status and response to immunization with polysaccharide vaccines of a healthy, congenitally asplenic woman.

Authors:  P J McElroy; F I Henderson; D L Brown
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

9.  Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.

Authors:  Dan M Granoff; Serena Giuntini; Flor A Gowans; Eduardo Lujan; Kelsey Sharkey; Peter T Beernink
Journal:  JCI Insight       Date:  2016-09-08

10.  Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus (SLE).

Authors:  A M Blasini; I L Stekman; M Leon-Ponte; D Caldera; M A Rodriguez
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.